Contenido Artículos científicos Open Access

Artículos científicos Open Access

Addendum needed on COVID-19 travel study – Authors' reply
Mathew V Kiang, et al
The Lancet Infectious Diseases
Correction to Lancet Infect Dis 2021; 21: 929–38
The Lancet Infectious Diseases
Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial
Bernadette C Young, et al
The Lancet
Daily antigen testing to reduce disruption when schools return
Russell M Viner, Archana Koirala
The Lancet
Prevention of host-to-host transmission by SARS-CoV-2 vaccines
Darius Mostaghimi, et al
The Lancet Infectious Diseases
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
Florence Ader, et al
The Lancet Infectious Diseases
Remdesivir, on the road to DisCoVeRy
Iwein Gyselinck, Wim Janssens
The Lancet Infectious Diseases
Considerations in boosting COVID-19 vaccine immune responses
Philip R Krause, et al
The Lancet
India's COVID-19 vaccination drive: key challenges and resolutions
Om Prakash Choudhary, et al
The Lancet Infectious Diseases
Bilateral anterior non-necrotising scleritis, anterior uveitis, and unilateral facial nerve palsy in paediatric inflammatory multisystem syndrome temporally associated with COVID-19
Meriam Islam, et al
The Lancet Rheumatology
Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina
Soledad González, et al
EClinicalMedicine
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
Yaping Wang, et al
EClinicalMedicine
Effectiveness of an Inactivated SARS-CoV-2 Vaccine
Artemy Okhotin
NEJM
Vaccine-Induced Thrombocytopenia with Severe Headache
Linda Schönborn, et al
NEJM
BNT162b2 Covid-19 Vaccine in Adolescents
Chen-Hsing Lin
NEJM

Página 27 de 490

Contenido

Contáctanos

Universidad No. 655 Colonia Santa María Ahuacatitlán, Cerrada Los Pinos y Caminera. Cuernavaca, Morelos, México.

comunicacion@insp.mx

(777)329 3000

www.insp.mx

¿De qué se trata tu petición?

Síguenos en nuestras redes sociales

El Instituto
Centros
Investigación
Suscríbete a nuestro Boletín Institucional
INSP logo
© 2022 INSP. Todos los derechos reservados.